The global human immunodeficiency virus (HIV) rapid test kits market is expected to grow at a CAGR of 5.5% during the forecast period, from 2021 to 2030. The growth of this market can be attributed to the increasing number of HIV cases and the rising awareness about HIV/AIDS among people. Rapid test kits are used for detecting HIV infection in blood or other body fluids, such as saliva or urine. These tests are highly sensitive and specific, which makes them an ideal choice for screening purposes. Rapid tests have been developed by various manufacturers across the globe, which has led to a rise in competition among these companies and has resulted in better quality products being offered at affordable prices.
Rapid immunoassay test is one type of rapid test kit that is used for detecting antibodies against HIV-1 and HIV-2 antigens in blood samples or other body fluids such as saliva or urine samples. This type of rapid test kit is available with different formats such as lateral flow assay (LFA), enzyme-linked immunosorbent assay (ELISA), chemiluminescence immunoassay (CLIA), etc, depending on their sensitivity levels and detection time periods required by customers. ELISA format is widely preferred due to its high sensitivity level and short detection time period; however, CLIA format offers faster results than ELISA format but it requires expensive equipment that may not be available everywhere across the world.
Rapid molecular diagnostic tests are another type of rapid testing kits that detect antibodies against HIV-1 antigens using nucleic acid amplification techniques like polymerase chain reaction (PCR). PCR technology offers higher sensitivity levels than LFA formats; however, it takes longer time periods for results to be generated compared with LFA formats because PCR needs more steps before final results can be obtained from samples tested using this technique.
Rapid test kits are used to detect the presence of HIV in a person's blood. The rapid test kits are designed to detect the presence of antibodies against HIV-1 and HIV-2.Rapid tests can be performed on whole blood, serum, plasma, or oral fluid.
Industry Growth Insights published a new data on “Human Immunodeficiency Virus (HIV) Rapid Test Kits Market”. The research report is titled “Human Immunodeficiency Virus (HIV) Rapid Test Kits Market research by Types (Rapid Immunoassay Test, Rapid Molecular Diagnostic Test), By Applications (Hospitals, Clinics, Government Organizations), By Players/Companies Roche, Siemens, Danaher, Abbott Laboratories, Bio-Rad Laboratories, AccuBioTech, BioMerieux, Qiagen, Meridian Bioscience, Hologic, Creative Diagnostics”.
Scope Of The Report
Report Attributes
Report Details
Report Title
Human Immunodeficiency Virus (HIV) Rapid Test Kits Market Research Report
By Type
Rapid Immunoassay Test, Rapid Molecular Diagnostic Test
By Application
Hospitals, Clinics, Government Organizations
By Companies
Roche, Siemens, Danaher, Abbott Laboratories, Bio-Rad Laboratories, AccuBioTech, BioMerieux, Qiagen, Meridian Bioscience, Hologic, Creative Diagnostics
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
239
Number of Tables & Figures
168
Customization Available
Yes, the report can be customized as per your need.
 Rapid Test Kits Industry Outlook.svg)
Global Human Immunodeficiency Virus (HIV) Rapid Test Kits Market Report Segments:
The global Human Immunodeficiency Virus (HIV) Rapid Test Kits market is segmented on the basis of:
Types
Rapid Immunoassay Test, Rapid Molecular Diagnostic Test
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Hospitals, Clinics, Government Organizations
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Roche
- Siemens
- Danaher
- Abbott Laboratories
- Bio-Rad Laboratories
- AccuBioTech
- BioMerieux
- Qiagen
- Meridian Bioscience
- Hologic
- Creative Diagnostics
 Rapid Test Kits Market Overview.svg)
Highlights of The Human Immunodeficiency Virus (HIV) Rapid Test Kits Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Rapid Immunoassay Test
- Rapid Molecular Diagnostic Test
- By Application:
- Hospitals
- Clinics
- Government Organizations
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Human Immunodeficiency Virus (HIV) Rapid Test Kits Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
 Rapid Test Kits Market Statistics.svg)
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Human Immunodeficiency Virus (HIV) Rapid Test Kits are a type of home test that can be used to detect the presence of HIV in saliva, blood, or other body fluids. These tests are typically used to screen for the virus in people who may be at risk for infection.
Some of the key players operating in the human immunodeficiency virus (hiv) rapid test kits market are Roche, Siemens, Danaher, Abbott Laboratories, Bio-Rad Laboratories, AccuBioTech, BioMerieux, Qiagen, Meridian Bioscience, Hologic, Creative Diagnostics.
The human immunodeficiency virus (hiv) rapid test kits market is expected to grow at a compound annual growth rate of 5.5%.
1. Executive Summary
2. Assumptions and Acronyms Used
3. Research Methodology
4. Human Immunodeficiency Virus (HIV) Rapid Test Kits Market Overview
4.1. Introduction
4.1.1. Market Taxonomy
4.1.2. Market Definition
4.2. Macro-Economic Factors
4.2.1. Industry Outlook
4.3. Human Immunodeficiency Virus (HIV) Rapid Test Kits Market Dynamics
4.3.1. Market Drivers
4.3.2. Market Restraints
4.3.3. Opportunity
4.3.4. Market Trends
4.4. Human Immunodeficiency Virus (HIV) Rapid Test Kits Market - Supply Chain
4.5. Global Human Immunodeficiency Virus (HIV) Rapid Test Kits Market Forecast
4.5.1. Human Immunodeficiency Virus (HIV) Rapid Test Kits Market Size (US$ Mn) and Y-o-Y Growth
4.5.2. Human Immunodeficiency Virus (HIV) Rapid Test Kits Market Size (000 Units) and Y-o-Y Growth
4.5.3. Human Immunodeficiency Virus (HIV) Rapid Test Kits Market Absolute $ Opportunity
5. Global Human Immunodeficiency Virus (HIV) Rapid Test Kits Market Analysis and Forecast by Type
5.1. Market Trends
5.2. Introduction
5.2.1. Basis Point Share (BPS) Analysis by Type
5.2.2. Y-o-Y Growth Projections by Type
5.3. Human Immunodeficiency Virus (HIV) Rapid Test Kits Market Size and Volume Forecast by Type
5.3.1. Rapid Immunoassay Test
5.3.2. Rapid Molecular Diagnostic Test
5.4. Absolute $ Opportunity Assessment by Type
5.5. Market Attractiveness/Growth Potential Analysis by Type
6. Global Human Immunodeficiency Virus (HIV) Rapid Test Kits Market Analysis and Forecast by Application
6.1. Market Trends
6.2. Introduction
6.2.1. Basis Point Share (BPS) Analysis by Application
6.2.2. Y-o-Y Growth Projections by Application
6.3. Human Immunodeficiency Virus (HIV) Rapid Test Kits Market Size and Volume Forecast by Application
6.3.1. Hospitals
6.3.2. Clinics
6.3.3. Government Organizations
6.4. Absolute $ Opportunity Assessment by Application
6.5. Market Attractiveness/Growth Potential Analysis by Application
7. Global Human Immunodeficiency Virus (HIV) Rapid Test Kits Market Analysis and Forecast by Sales Channel
7.1. Market Trends
7.2. Introduction
7.2.1. Basis Point Share (BPS) Analysis by Sales Channel
7.2.2. Y-o-Y Growth Projections by Sales Channel
7.3. Human Immunodeficiency Virus (HIV) Rapid Test Kits Market Size and Volume Forecast by Sales Channel
7.3.1. Manufacturer/Distributor/Service Provider
7.3.2. Aftermarket
7.4. Absolute $ Opportunity Assessment by Sales Channel
7.5. Market Attractiveness/Growth Potential Analysis by Sales Channel
8. Global Human Immunodeficiency Virus (HIV) Rapid Test Kits Market Analysis and Forecast by Region
8.1. Market Trends
8.2. Introduction
8.2.1. Basis Point Share (BPS) Analysis by Region
8.2.2. Y-o-Y Growth Projections by Region
8.3. Human Immunodeficiency Virus (HIV) Rapid Test Kits Market Size and Volume Forecast by Region
8.3.1. North America
8.3.2. Latin America
8.3.3. Europe
8.3.4. Asia Pacific
8.3.5. Middle East and Africa (MEA)
8.4. Absolute $ Opportunity Assessment by Region
8.5. Market Attractiveness/Growth Potential Analysis by Region
8.6. Global Human Immunodeficiency Virus (HIV) Rapid Test Kits Demand Share Forecast, 2019-2026
9. North America Human Immunodeficiency Virus (HIV) Rapid Test Kits Market Analysis and Forecast
9.1. Introduction
9.1.1. Basis Point Share (BPS) Analysis by Country
9.1.2. Y-o-Y Growth Projections by Country
9.2. North America Human Immunodeficiency Virus (HIV) Rapid Test Kits Market Size and Volume Forecast by Country
9.2.1. U.S.
9.2.2. Canada
9.3. Absolute $ Opportunity Assessment by Country
9.4. North America Human Immunodeficiency Virus (HIV) Rapid Test Kits Market Size and Volume Forecast by Application
9.4.1. Hospitals
9.4.2. Clinics
9.4.3. Government Organizations
9.5. Basis Point Share (BPS) Analysis by Application
9.6. Y-o-Y Growth Projections by Application
9.7. North America Human Immunodeficiency Virus (HIV) Rapid Test Kits Market Size and Volume Forecast by Type
9.7.1. Rapid Immunoassay Test
9.7.2. Rapid Molecular Diagnostic Test
9.8. Basis Point Share (BPS) Analysis by Type
9.9. Y-o-Y Growth Projections by Type
9.10. Market Attractiveness/Growth Potential Analysis
9.10.1. By Country
9.10.2. By Product Type
9.10.3. By Application
9.10.4. By Sales Channel
9.11. North America Human Immunodeficiency Virus (HIV) Rapid Test Kits Demand Share Forecast, 2019-2026
10. Latin America Human Immunodeficiency Virus (HIV) Rapid Test Kits Market Analysis and Forecast
10.1. Introduction
10.1.1. Basis Point Share (BPS) Analysis by Country
10.1.2. Y-o-Y Growth Projections by Country
10.1.3. Latin America Average Pricing Analysis
10.2. Latin America Human Immunodeficiency Virus (HIV) Rapid Test Kits Market Size and Volume Forecast by Country
10.2.1. Brazil
10.2.2. Mexico
10.2.3. Rest of Latin America
10.3. Absolute $ Opportunity Assessment by Country
10.4. Latin America Human Immunodeficiency Virus (HIV) Rapid Test Kits Market Size and Volume Forecast by Application
10.4.1. Hospitals
10.4.2. Clinics
10.4.3. Government Organizations
10.5. Basis Point Share (BPS) Analysis by Application
10.6. Y-o-Y Growth Projections by Application
10.7. Latin America Human Immunodeficiency Virus (HIV) Rapid Test Kits Market Size and Volume Forecast by Type
10.7.1. Rapid Immunoassay Test
10.7.2. Rapid Molecular Diagnostic Test
10.8. Basis Point Share (BPS) Analysis by Type
10.9. Y-o-Y Growth Projections by Type
10.10. Market Attractiveness/Growth Potential Analysis
10.10.1. By Country
10.10.2. By Product Type
10.10.3. By Application
10.10.4. By Sales Channel
10.11. Latin America Human Immunodeficiency Virus (HIV) Rapid Test Kits Demand Share Forecast, 2019-2026
11. Europe Human Immunodeficiency Virus (HIV) Rapid Test Kits Market Analysis and Forecast
11.1. Introduction
11.1.1. Basis Point Share (BPS) Analysis by Country
11.1.2. Y-o-Y Growth Projections by Country
11.1.3. Europe Average Pricing Analysis
11.2. Europe Human Immunodeficiency Virus (HIV) Rapid Test Kits Market Size and Volume Forecast by Country
11.2.1. Germany
11.2.2. France
11.2.3. Italy
11.2.4. U.K.
11.2.5. Spain
11.2.6. Russia
11.2.7. Rest of Europe
11.3. Absolute $ Opportunity Assessment by Country
11.4. Europe Human Immunodeficiency Virus (HIV) Rapid Test Kits Market Size and Volume Forecast by Application
11.4.1. Hospitals
11.4.2. Clinics
11.4.3. Government Organizations
11.5. Basis Point Share (BPS) Analysis by Application
11.6. Y-o-Y Growth Projections by Application
11.7. Europe Human Imunodeficiency Virus (HIV) Rapid Test Kits Market Size and Volume Forecast by Type
11.7.1. Rapid Immunoassay Test
11.7.2. Rapid Molecular Diagnostic Test
11.8. Basis Point Share (BPS) Analysis by Type
11.9. Y-o-Y Growth Projections by Type
11.10. Market Attractiveness/Growth Potential Analysis
11.10.1. By Country
11.10.2. By Product Type
11.10.3. By Application
11.10.4. By Sales Channel
11.11. Europe Human Immunodeficiency Virus (HIV) Rapid Test Kits Demand Share, 2019-2026
12. Asia Pacific Human Immunodeficiency Virus (HIV) Rapid Test Kits Market Analysis and Forecast
12.1. Introduction
12.1.1. Basis Point Share (BPS) Analysis by Country
12.1.2. Y-o-Y Growth Projections by Country
12.1.3. Asia Pacific Average Pricing Analysis
12.2. Asia Pacific Human Immunodeficiency Virus (HIV) Rapid Test Kits Market Size and Volume Forecast by Country
12.2.1. China
12.2.2. Japan
12.2.3. South Korea
12.2.4. India
12.2.5. Australia
12.2.6. Rest of Asia Pacific (APAC)
12.3. Absolute $ Opportunity Assessment by Country
12.4. Asia Pacific Human Immunodeficiency Virus (HIV) Rapid Test Kits Market Size and Volume Forecast by Application
12.4.1. Hospitals
12.4.2. Clinics
12.4.3. Government Organizations
12.5. Basis Point Share (BPS) Analysis by Application
12.6. Y-o-Y Growth Projections by Application
12.7. Asia Pacific Human Immunodeficiency Virus (HIV) Rapid Test Kits Market Size and Volume Forecast by Type
12.7.1. Rapid Immunoassay Test
12.7.2. Rapid Molecular Diagnostic Test
12.8. Basis Point Share (BPS) Analysis by Type
12.9. Y-o-Y Growth Projections by Type
12.10. Market Attractiveness/Growth Potential Analysis
12.10.1. By Country
12.10.2. By Product Type
12.10.3. By Application
12.10.4. By Sales Channel
12.11. Asia Pacific Human Immunodeficiency Virus (HIV) Rapid Test Kits Demand Share, 2019-2026
13. Middle East & Africa Human Immunodeficiency Virus (HIV) Rapid Test Kits Market Analysis and Forecast
13.1. Introduction
13.1.1. Basis Point Share (BPS) Analysis by Country
13.1.2. Y-o-Y Growth Projections by Country
13.1.3. Asia Pacific Average Pricing Analysis
13.2. Middle East & Africa Human Immunodeficiency Virus (HIV) Rapid Test Kits Market Size and Volume Forecast by Country
13.2.1. Saudi Arabia
13.2.2. South Africa
13.2.3. UAE
13.2.4. Rest of Middle East & Africa (MEA)
13.3. Absolute $ Opportunity Assessment by Country
13.4. Middle East & Africa Human Immunodeficiency Virus (HIV) Rapid Test Kits Market Size and Volume Forecast by Application
13.4.1. Hospitals
13.4.2. Clinics
13.4.3. Government Organizations
13.5. Basis Point Share (BPS) Analysis by Application
13.6. Y-o-Y Growth Projections by Application
13.7. Middle East & Africa Human Immunodeficiency Virus (HIV) Rapid Test Kits Market Size and Volume Forecast by Type
13.7.1. Rapid Immunoassay Test
13.7.2. Rapid Molecular Diagnostic Test
13.8. Basis Point Share (BPS) Analysis by Type
13.9. Y-o-Y Growth Projections by Type
13.10. Market Attractiveness/Growth Potential Analysis
13.10.1. By Country
13.10.2. By Product Type
13.10.3. By Application
13.10.4. By Sales Channel
13.11. Middle East & Africa Human Immunodeficiency Virus (HIV) Rapid Test Kits Demand Share, 2019-2026
14. Competition Landscape
14.1. Global Human Immunodeficiency Virus (HIV) Rapid Test Kits Market: Market Share Analysis
14.2. Human Immunodeficiency Virus (HIV) Rapid Test Kits Distributors and Customers
14.3. Human Immunodeficiency Virus (HIV) Rapid Test Kits Market: Competitive Dashboard
14.4. Company Profiles (Details Overview, Financials, Developments, Strategy)
14.4.1. Roche
14.4.1.1. Overview
14.4.1.2. Financials
14.4.1.3. Developments
14.4.1.4. Strategic Outlook
14.4.2. Siemens
14.4.2.1. Overview
14.4.2.2. Financials
14.4.2.3. Developments
14.4.2.4. Strategic Outlook
14.4.3. Danaher
14.4.3.1. Overview
14.4.3.2. Financials
14.4.3.3. Developments
14.4.3.4. Strategic Outlook
14.4.4. Abbott Laboratories
14.4.4.1. Overview
14.4.4.2. Financials
14.4.4.3. Developments
14.4.4.4. Strategic Outlook
14.4.5. Bio-Rad Laboratories
14.4.5.1. Overview
14.4.5.2. Financials
14.4.5.3. Developments
14.4.5.4. Strategic Outlook
14.4.6. AccuBioTech
14.4.6.1. Overview
14.4.6.2. Financials
14.4.6.3. Developments
14.4.6.4. Strategic Outlook
14.4.7. BioMerieux
14.4.7.1. Overview
14.4.7.2. Financials
14.4.7.3. Developments
14.4.7.4. Strategic Outlook
14.4.8. Qiagen
14.4.8.1. Overview
14.4.8.2. Financials
14.4.8.3. Developments
14.4.8.4. Strategic Outlook
14.4.9. Meridian Bioscience
14.4.9.1. Overview
14.4.9.2. Financials
14.4.9.3. Developments
14.4.9.4. Strategic Outlook
14.4.10. Hologic
14.4.10.1. Overview
14.4.10.2. Financials
14.4.10.3. Developments
14.4.10.4. Strategic Outlook
14.4.11. Creative Diagnostics
14.4.11.1. Overview
14.4.11.2. Financials
14.4.11.3. Developments
14.4.11.4. Strategic Outlook
14.4.12. COMPANY 12
14.4.12.1. Overview
14.4.12.2. Financials
14.4.12.3. Developments
14.4.12.4. Strategic Outlook
14.4.13. COMPANY 13
14.4.13.1. Overview
14.4.13.2. Financials
14.4.13.3. Developments
14.4.13.4. Strategic Outlook
14.4.14. COMPANY 14
14.4.14.1. Overview
14.4.14.2. Financials
14.4.14.3. Developments
14.4.14.4. Strategic Outlook
14.4.15. COMPANY 15
14.4.15.1. Overview
14.4.15.2. Financials
14.4.15.3. Developments
14.4.15.4. Strategic Outlook
14.4.16. COMPANY 16
14.4.16.1. Overview
14.4.16.2. Financials
14.4.16.3. Developments
14.4.16.4. Strategic Outlook
14.4.17. COMPANY 17
14.4.17.1. Overview
14.4.17.2. Financials
14.4.17.3. Developments
14.4.17.4. Strategic Outlook
14.4.18. COMPANY 18
14.4.18.1. Overview
14.4.18.2. Financials
14.4.18.3. Developments
14.4.18.4. Strategic Outlook
14.4.19. COMPANY 19
14.4.19.1. Overview
14.4.19.2. Financials
14.4.19.3. Developments
14.4.19.4. Strategic Outlook
14.4.20. COMPANY 20
14.4.20.1. Overview
14.4.20.2. Financials
14.4.20.3. Developments
14.4.20.4. Strategic Outlook
